14159 Capital , Llc Insider Profile
4 Followers
14159 Capital , Llc, Director, Ten Percent Owner at Incyte, holds 83.53K shares in Ocera Therapeutics (Ticker: OCRX), holds 227.84K shares in Genomic Health (Ticker: GHDX), holds 360.23K shares in XOMA Royalty Corporation (Ticker: XOMA). Most recently, 14159 Capital , Llc Bought ― shares of Ocera Therapeutics on Mar 14, 2012 for an estimated value of $81.04K.
14159 Capital , Llc's Trading History
| OCRXOcera Therapeutics | Mar 14, 2012 | ― | Informative Buy | 81.04K | $149.51K | |
| GHDXGenomic Health | Mar 09, 2012 | ― | Informative Buy | 33.08K | $14.45M | |
| XOMAXOMA Royalty Corporation | Mar 08, 2012 | ― | Informative Buy | ― | $14.47M | |
| PCYCPharmacyclics | Jan 26, 2012 | ― | Informative Buy | 234.10K | ― | |
| INCYIncyte | Jan 17, 2012 | Director, Ten Percent Owner | Informative Buy | 239.33K | $42.80M | |
| GEVASynageva | Jan 09, 2012 | ― | Uninformative Buy | 732.46K | ― | |
| SGENSeagen | Sep 08, 2011 | ― | Informative Buy | 30.28K | $73.92M | |
| AUXLAuxilium | Aug 03, 2011 | ― | Informative Sell | 307.08K | ― | |
| HRTXHeron Therapeutics | Oct 28, 2009 | Ten Percent Owner | Informative Buy | ― | $44.47K | |
| BCRXBioCryst | Jun 01, 2009 | Ten Percent Owner | Informative Sell | 66.89K | $900.17K | |
| VPHMViropharma | May 08, 2009 | ― | Informative Buy | ― | ― | |
| ACGNAceragen | ― | ― | ― | $4.89K |
You May Also Like
14159 Capital , Llc insider profile FAQ
What is the percentage of profitable transactions made by 14159 Capital , Llc?
The percentage of profitable transactions made by 14159 Capital , Llc is 66%.
What is the average return per transaction made by 14159 Capital , Llc?
The average return per transaction made by 14159 Capital , Llc is 71.60%.
What stocks does 14159 Capital , Llc hold?
14159 Capital , Llc holds: INCY, SGEN, GHDX, HRTX, BCRX, OCRX, XOMA, ACGN, AUXL, PCYC, GEVA, VPHM stocks.
What was 14159 Capital , Llc’s latest transaction?
14159 Capital , Llc’s latest transaction was an Informative Buy of $81.04K.
What was 14159 Capital , Llc's most profitable transaction?
14159 Capital , Llc’s most profitable transaction was an Informative Buy of PCYC stock on August 24, 2011. The return on the trade was 524.90%.
What is 14159 Capital , Llc's role in Incyte?
14159 Capital , Llc's role in Incyte is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
